求文献

drgaoh

求大肠癌肿瘤干细胞与转移相关的研究文献

bowangl

回复 drgaoh 的帖子
' w) J- k! {) F: B/ ]4 Z
! U7 ~9 i" d2 MHi Drgaoh,4 P# M! D5 U& |8 u0 {
0 g( }+ _" M0 h7 U% I$ k! b  y
There are some references related to your request.
; I3 y) ^5 p( I# q( [4 a
' f& J" \: Z% d% ]# A% r
) U; N- e/ t: D6 {1. Colon cancer stem cells: implications in carcinogenesis.
* j4 t5 G! H# r. i5 NSanders MA, Majumdar AP.
" ^+ |* w' U$ `4 n% `" RFront Biosci. 2011 Jan 1;16:1651-62.
/ |8 E  W. ^5 M* a, S8 RPMID: 21196254 [PubMed - in process( w% T! a: I. N% b" }- @  Q1 a* m
% ?' {% c2 F8 z7 h) O* P) Q
2.
( }; G' U  h4 [  A) g, E- r; [The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
! Z: k1 U2 q: \$ ]* C  gHorst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, Jung A.+ S! E) T7 _  g' {& l, X
J Pathol. 2009 Dec;219(4):427-34.
5 r' O4 I; Q/ R* T5 j% I: sPMID: 19621338 [PubMed - indexed for MEDLINE
- O6 P3 d; W" Q2 P
. M2 }* M, Z' a6 c: N; g3.
6 C2 u3 D1 [# fPhenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
* a" H: Z0 T; h( tBotchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.# B  p! ?5 g$ x
Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.4 r  s! d1 I0 i3 E
PMID: 19451087 [PubMed - indexed for MEDLINE]
6 \0 k8 Y, |, B! g/ V( C- K2 F$ i; \: g! j# z3 ?' L! z4 @
4.
1 @+ b. b% ^( f# l2 N: h# n0 T9 ^Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver.6 B8 |) r% R& F, V3 M
Zou GM.5 M/ L3 l" e- r3 C4 k
J Cell Physiol. 2008 Dec;217(3):598-604. Review.
# B3 j1 q' O4 |, {) QPMID: 18651561 [PubMed - indexed for MEDLINE]
* ?7 ^9 |* S4 y5 ~. S* S( r7 ]7 {/ s/ a/ h8 u
5.6 b. ^3 {1 q) w1 R/ n
Human colon cancer stem cells: a new paradigm in gastrointestinal oncology.( {2 n- T" R' [" Z3 q0 g" {. I. R
Boman BM, Huang E.
$ V  a0 U6 g; j  @/ V: O" ]* OJ Clin Oncol. 2008 Jun 10;26(17):2828-38. Review.3 B9 C" _- J# K2 A0 X; J
PMID: 18539961 [PubMed - indexed for MEDLINE]6 d* g/ K7 v, c/ w
! ]/ G, @2 }5 K" F
6.
" q5 S" l4 a$ H3 E- CCD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
4 ?1 d+ y; m# EShmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S.
& a5 v9 j3 T! M* W3 J- b' Q- dJ Clin Invest. 2008 Jun;118(6):2111-20.! @/ H$ Z6 R1 R9 x- h- ~
PMID: 18497886 [PubMed - indexed for MEDLINE]
- F: |+ \' r" F3 g- c/ I8 k' @9 c- |5 t* R
7.
7 k5 ]0 @" O8 n/ Y% E( S6 q0 qIs CD133 a marker of metastatic colon cancer stem cells?
+ x3 P4 x( s, i: }6 z* hLaBarge MA, Bissell MJ.. J" C% O9 l" t
J Clin Invest. 2008 Jun;118(6):2021-4.# d# n- M$ o# |7 X% Z' L/ y" b
PMID: 18497883 [PubMed - indexed for MEDLINE]
1 J' a1 ]+ K( @  m/ Y